Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients.

Ozawa T, Tokunaga J, Arakawa M, Ishikawa A, Takeuchi R, Mezaki N, Miura T, Sakai N, Hokari M, Takeshima A, Utsumi K, Kondo T, Yokoseki A, Nishizawa M.

J Neurol. 2013 Aug;260(8):2073-7. doi: 10.1007/s00415-013-6944-9. Epub 2013 May 8.

2.

The circulating level of leptin and blood pressure in patients with multiple system atrophy.

Ozawa T, Tokunaga J, Arakawa M, Ishikawa A, Takeuchi R, Yokoseki A, Sone H, Nishizawa M.

J Neurol Sci. 2014 Dec 15;347(1-2):349-51. doi: 10.1016/j.jns.2014.09.045. Epub 2014 Oct 2.

PMID:
25304054
3.

[Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].

Rouco I, Gómez JC, Lezcano E, Aniel-Quiroga MA, Velasco F, Barcena J, Pérez Bas M, Hurtado P, Cruz Lachén M, Zarranz JJ.

Neurologia. 2006 Apr;21(3):119-23. Spanish.

PMID:
16575624
4.

Autonomic dysfunction in different subtypes of multiple system atrophy.

Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schöls L, Reichmann H, Berg D, Ziemssen T.

Mov Disord. 2008 Sep 15;23(12):1766-72. doi: 10.1002/mds.22187.

PMID:
18661564
5.

Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy.

Deguchi K, Sasaki I, Tsukaguchi M, Kamoda M, Touge T, Takeuchi H, Kuriyama S.

J Neurol Sci. 2002 Jul 15;199(1-2):31-7.

PMID:
12084439
6.

Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.

Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE.

Neurology. 2006 Feb 14;66(3):378-83.

PMID:
16476936
8.

Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.

Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, Filippini G.

Neurol Sci. 2001 Jun;22(3):247-51.

PMID:
11731878
9.

MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.

Yabe I, Soma H, Takei A, Fujiki N, Yanagihara T, Sasaki H.

J Neurol Sci. 2006 Nov 15;249(2):115-21. Epub 2006 Jul 10.

PMID:
16828805
10.

Sleep disorders and their determinants in multiple system atrophy.

Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):798-800.

11.

Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.

Nicoletti G, Rizzo G, Barbagallo G, Tonon C, Condino F, Manners D, Messina D, Testa C, Arabia G, Gambardella A, Lodi R, Quattrone A.

Radiology. 2013 Jun;267(3):843-50. doi: 10.1148/radiol.12120364. Epub 2013 Jan 17.

PMID:
23329659
12.

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.

Köllensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK; EMSA-SG.

Mov Disord. 2010 Nov 15;25(15):2604-12. doi: 10.1002/mds.23192.

PMID:
20922810
13.

Reduced bowel sounds in Parkinson's disease and multiple system atrophy patients.

Ozawa T, Saji E, Yajima R, Onodera O, Nishizawa M.

Clin Auton Res. 2011 Jun;21(3):181-4. doi: 10.1007/s10286-010-0102-6. Epub 2010 Dec 23.

PMID:
21181426
14.

Assessment of cardiovascular autonomic dysfunction in multiple system atrophy.

Kitae S, Murata Y, Tachiki N, Okazaki M, Harada T, Nakamura S.

Clin Auton Res. 2001 Feb;11(1):39-44.

PMID:
11503950
15.

Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy.

Fukushima T, Asahina M, Fujinuma Y, Yamanaka Y, Katagiri A, Mori M, Kuwabara S.

J Neurol. 2013 Feb;260(2):475-83. doi: 10.1007/s00415-012-6660-x. Epub 2012 Sep 15.

PMID:
22983428
16.

Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.

Han YH, Lee JH, Kang BM, Mun CW, Baik SK, Shin YI, Park KH.

J Neurol Sci. 2013 Feb 15;325(1-2):29-35. doi: 10.1016/j.jns.2012.11.009. Epub 2012 Dec 20.

PMID:
23260321
17.

Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy.

Fetoni V, Soliveri P, Monza D, Testa D, Girotti F.

J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):541-4.

18.

Clinical features of dystonia in atypical parkinsonism.

Godeiro-Junior C, Felício AC, Barsottini OG, Aguiar PM, Silva SM, Borges V, Ferraz HB.

Arq Neuropsiquiatr. 2008 Dec;66(4):800-4.

19.

MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.

Chung EJ, Lee WY, Yoon WT, Kim BJ, Lee GH.

Mov Disord. 2009 Aug 15;24(11):1650-5. doi: 10.1002/mds.22649.

PMID:
19514077
20.

Enhanced temporal pain processing in multiple system atrophy.

Perrotta A, Bolla M, Serrao M, Paparatti M, Tassorelli C, Pierelli F, Sandrini G.

Neurosci Lett. 2013 Oct 25;555:203-8. doi: 10.1016/j.neulet.2013.09.035. Epub 2013 Sep 26.

PMID:
24076144
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk